SIM
AGIO icon

Spark Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Spark Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,605
Closed -$410K – 373
2019
Q4 		$410K Sell
8,605
-7,869
-48% -$297K 0.05% 368
2019
Q3 		$533K Sell
16,474
-78,026
-83% -$3.23M 0.07% 246
2019
Q2 		$4.71M Buy
94,500
+10,100
+12% +$540K 0.33% 98
2019
Q1 		$5.69M Sell
84,400
-51,200
-38% -$2.98M 0.26% 112
2018
Q4 		$6.25M Buy
135,600
+31,300
+30% +$1.93M 0.43% 70
2018
Q3 		$8.04M Buy
+104,300
New +$8.39M 0.46% 44
2018
Q1 		– Sell
-14,600
Closed -$834K – 600
2017
Q4 		$834K Sell
14,600
-34,600
-70% -$2.18M 0.04% 384
2017
Q3 		$3.28M Sell
49,200
-35,500
-42% -$2.13M 0.18% 191
2017
Q2 		$4.36M Buy
84,700
+49,400
+140% +$2.53M 0.27% 119
2017
Q1 		$2.06M Sell
35,300
-14,700
-29% -$705K 0.13% 246
2016
Q4 		$2.09M Buy
+50,000
New +$2.62M 0.17% 191
2014
Q3 		– Sell
-31,300
Closed -$1.43M – 665
2014
Q2 		$1.43M Buy
+31,300
New +$1.28M 0.21% 163

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Spark Investment Management's AGIO Position: Q1 2020 in Review

Spark Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 8,605 shares — an estimated $410K sold.

Spark Investment Management first reported a position in AGIO in Q2 2014 and held it in 12 quarters. The position peaked at $8.04M in Q3 2018. 197 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

  • Spark Investment Management reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 8,605 Agios Pharmaceuticals shares in Q1 2020, an estimated $410K.
  • Spark Investment Management first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 12 quarters.
  • Spark Investment Management's Agios Pharmaceuticals position peaked at $8.04M in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.